PSA also allows for the early detection of latent prostate cancer that often does not develop into a significant disease and is often elevated under benign conditions such as inflammation or hyperplasia, and this lack of PSA specificity results in over-diagnosis [17]. Here, KLK3 is linked to prostate carcinoma.